{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:55:33Z","timestamp":1791172533611,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.jcv.2011.07.002","type":"journal-article","created":{"date-parts":[[2011,8,7]],"date-time":"2011-08-07T01:05:01Z","timestamp":1312679101000},"page":"181-186","source":"Crossref","is-referenced-by-count":32,"title":["High correlation between the Roche COBAS\u00ae AmpliPrep\/COBAS\u00ae TaqMan\u00ae HIV-1, v2.0 and the Abbott m2000 RealTime HIV-1 assays for quantification of viral load in HIV-1 B and non-B subtypes"],"prefix":"10.1016","volume":"52","author":[{"given":"J.C.","family":"Karasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Dziezuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Quennery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"F\u00f6rster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Reischl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Colucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Schoener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Seguin-Devaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Schmit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2011.07.002_bib0005","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJM199610103351502","article-title":"The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter AIDS Clinical Trials Group Study 175 Virology Study Team","volume":"335","author":"Katzenstein","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcv.2011.07.002_bib0010","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJM199602153340703","article-title":"Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS Veterans Affairs Cooperative Study Group on AIDS","volume":"334","author":"O\u2019Brien","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcv.2011.07.002_bib0020","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1128\/JCM.32.2.292-300.1994","article-title":"Rapid simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection","volume":"32","author":"Mulder","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2011.07.002_bib0025","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1086\/595707","article-title":"Detection of HIV type 1 load by the Roche Cobas TaqMan assay in patients with viral loads previously undetectable by the Roche Cobas Amplicor Monitor","volume":"48","author":"Gatanaga","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcv.2011.07.002_bib0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/QAI.0b013e31819e721b","article-title":"Increased reporting of detectable plasma HIV-1 RNA levels at the critical threshold of 50 copies per milliliter with the Taqman assay in comparison to the Amplicor assay","volume":"51","author":"Lima","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jcv.2011.07.002_bib0035","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/QAI.0b013e3181aa13b3","article-title":"Increased frequency of HIV-1 viral load blip rate observed after switching from Roche Cobas Amplicor to Cobas Taqman assay","volume":"51","author":"Smit","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jcv.2011.07.002_bib0040","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1128\/JCM.00973-07","article-title":"Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep\/COBAS TaqMan HIV-1 assays","volume":"45","author":"Damond","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2011.07.002_bib0045","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/QAI.0b013e31803260df","article-title":"Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes","volume":"44","author":"Gueudin","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jcv.2011.07.002_bib0050","unstructured":"Grimwood National Antiretroviral Treatment Guidelines; 2004."},{"key":"10.1016\/j.jcv.2011.07.002_bib0055","unstructured":"WHO. Rapid advice \u2013 antiretroviral therapy for HIV infection in adults and adolescents. World Health Organization 2009. http:\/\/www.who.int\/hiv\/pub\/av\/rapid-advice-art; 2009."},{"key":"10.1016\/j.jcv.2011.07.002_bib0060","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1093\/nar\/gkm551","article-title":"Thermodynamically modulated partially double-stranded linear DNA probe design for homogeneous real-time PCR","volume":"35","author":"Huang","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jcv.2011.07.002_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2007.03.009","article-title":"Partially double-stranded linear DNA probes: novel design for sensitive detection of genetically polymorphic targets","volume":"144","author":"Luk","year":"2007","journal-title":"J Virol Methods"},{"key":"10.1016\/j.jcv.2011.07.002_bib0070","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1128\/JCM.00727-09","article-title":"Performance of the new Roche Cobas AmpliPrep-Cobas TaqMan version 2.0 human immunodeficiency virus type 1 assay","volume":"47","author":"Scott","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2011.07.002_bib0075","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1128\/JCM.01409-09","article-title":"Evaluation of an upgraded version of the Roche Cobas AmpliPrep\/Cobas TaqMan HIV-1 test for HIV-1 load quantification","volume":"48","author":"Damond","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2011.07.002_bib0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jcv.2010.06.004","article-title":"Improved HIV-1 RNA quantitation by COBAS AmpliPrep\/COBAS TaqMan HIV-1 Test, v2.0 using a novel dual-target approach","volume":"49","author":"Sizmann","year":"2010","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcv.2011.07.002_bib0085","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3851\/IMP1427","article-title":"Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individuals","volume":"14","author":"Taylor","year":"2009","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jcv.2011.07.002_bib0090","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jviromet.2009.08.013","article-title":"Evaluation of the Abbott m2000rt RealTime HIV-1 assay with manual sample preparation compared with the ROCHE COBAS AmpliPrep\/AMPLICOR HIV-1 MONITOR v1.5 using specimens from East Africa","volume":"162","author":"Crump","year":"2009","journal-title":"J Virol Methods"},{"key":"10.1016\/j.jcv.2011.07.002_bib0095","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1128\/JCM.01832-09","article-title":"Performance evaluation of the new Roche Cobas AmpliPrep\/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA","volume":"48","author":"Pas","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2011.07.002_bib0100","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1128\/JCM.01761-08","volume":"47","author":"Scott","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2011.07.002_bib0105","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1128\/JCM.02231-08","article-title":"Comparison of the Abbott realtime human immunodeficiency virus type 1 (HIV-1) assay to the Cobas AmpliPrep\/Cobas TaqMan HIV-1 test: workflow, reliability, and direct costs","volume":"47","author":"Sloma","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2011.07.002_bib0110","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jviromet.2006.06.010","article-title":"Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from London: comparison to VERSANT HIV-1 RNA 3.0, AMPLICOR HIV-1 MONITOR v1.5, and LCx HIV RNA Quantitative assays","volume":"137","author":"Swanson","year":"2006","journal-title":"J Virol Methods"},{"key":"10.1016\/j.jcv.2011.07.002_bib0115","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00061-11","article-title":"Upgraded Cobas Ampliprep-Cobas TaqMan Version 2.0 HIV-1 RNA quantification assay versus first version: correction of underestimations","author":"Wirden","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2011.07.002_bib0120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1743-422X-8-10","article-title":"Comparative evaluation of the performance of the Abbott RealTime HIV-1 assay for measurement of HIV-1 plasma viral load on genetically diverse samples from Greece","volume":"8","author":"Katsoulidou","year":"2011","journal-title":"Virol J"},{"key":"10.1016\/j.jcv.2011.07.002_bib0125","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jviromet.2011.03.014","article-title":"Performance evaluation of the COBAS\/TaqMan HIV-1 v2.0 in HIV-1 positive patients with low viral load: a comparative study","volume":"173","author":"Paba","year":"2011","journal-title":"J Virol Methods"},{"key":"10.1016\/j.jcv.2011.07.002_bib0130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/QAI.0b013e3182099891","article-title":"Comparative RNA quantification of HIV-1 group M and non-M with the Roche Cobas AmpliPrep\/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR assays","volume":"56","author":"Sire","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jcv.2011.07.002_bib0135","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jcv.2010.08.016","article-title":"Lack of correlation between three commercial platforms for the evaluation of human immunodeficiency virus type 1 (HIV-1) viral load at the clinically critical lower limit of quantification","volume":"49","author":"Yan","year":"2010","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcv.2011.07.002_bib0140","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1128\/JCM.01688-10","article-title":"HIV-1 load comparison using four commercial real-time assays","volume":"49","author":"Bourlet","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2011.07.002_bib0145","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1128\/JCM.01285-10","article-title":"Comparative evaluation of the Roche Cobas AmpliPrep\/Cobas TaqMan HIV-1 version 2 test using the TaqMan 48 analyzer and the Abbott RealTime HIV-1 assay","volume":"49","author":"van Rensburg","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2011.07.002_bib0150","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jcv.2010.10.017","article-title":"Accuracy to 2nd International HIV-1 RNA WHO Standard: assessment of three generations of quantitative HIV-1 RNA nucleic acid amplification tests","volume":"50","author":"Glaubitz","year":"2011","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcv.2011.07.002_bib0155","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1128\/JCM.00221-07","article-title":"Comparative evaluation of the automated Roche TaqMan real-time quantitative human immunodeficiency virus type 1 RNA PCR assay and the Roche AMPLICOR Version 1.5 conventional PCR assay","volume":"45","author":"Oliver","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2011.07.002_bib0160","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jcv.2010.01.008","article-title":"Viral load assay sensitivity and low level viremia in HAART treated HIV patients","volume":"47","author":"Verhofstede","year":"2010","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcv.2011.07.002_bib0165","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/508655","article-title":"Rate of viral evolution and risk of losing future drug options in heavily pretreated, HIV-infected patients who continue to receive a stable, partially suppressive treatment regimen","volume":"43","author":"Hatano","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcv.2011.07.002_bib0170","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jinf.2010.11.001","article-title":"The significance of very low-level viraemia detected by sensitive viral load assays in HIV infected patients on HAART","volume":"62","author":"Widdrington","year":"2011","journal-title":"J Infect"},{"key":"10.1016\/j.jcv.2011.07.002_bib0175","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1086\/592693","article-title":"Increased detectability of plasma HIV-1 RNA after introduction of a new assay and altered specimen-processing procedures","volume":"47","author":"Rebeiro","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcv.2011.07.002_bib0180","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1310\/hct1002-116","article-title":"Low-level viremia in HIV-1 infection: consequences and implications for switching to a new regimen","volume":"10","author":"Cohen","year":"2009","journal-title":"HIV Clin Trials"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653211002770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653211002770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T03:02:07Z","timestamp":1592794927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653211002770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1386653211002770"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2011.07.002","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}